Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-10-08

FDA Approved: PREGABALIN — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Camber Pharmaceuticals' original Abbreviated New Drug Application for pregabalin, a generic version of the brand product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

ORIG AP for PREGABALIN (PREGABALIN)